Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Avalo Therapeutics, Inc. - Common Stock (NQ:AVTX)

11.40 +1.64 (+16.80%)
Streaming Delayed Price Updated: 1:11 PM EDT, Sep 17, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 502,834
Open 9.840
Bid (Size) 11.30 (1)
Ask (Size) 11.50 (1)
Prev. Close 9.760
Today's Range 9.840 - 11.76
52wk Range 3.390 - 16.00
Shares Outstanding 96,008,951
Dividend Yield N/A

Performance

YTD
+35.2%
+35.2%
1 Month
+25.8%
+25.8%
3 Month
+155.0%
+155.0%
6 Month
+46.7%
+46.7%
1 Year
+31.9%
+31.9%

Frequently Asked Questions

Is Avalo Therapeutics, Inc. - Common Stock publicly traded?
Yes, Avalo Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Avalo Therapeutics, Inc. - Common Stock trade on?
Avalo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalo Therapeutics, Inc. - Common Stock?
The ticker symbol for Avalo Therapeutics, Inc. - Common Stock is AVTX on the Nasdaq Stock Market
What is the current price of Avalo Therapeutics, Inc. - Common Stock?
The current price of Avalo Therapeutics, Inc. - Common Stock is 11.40
When was Avalo Therapeutics, Inc. - Common Stock last traded?
The last trade of Avalo Therapeutics, Inc. - Common Stock was at 09/17/25 01:11 PM ET
What is the market capitalization of Avalo Therapeutics, Inc. - Common Stock?
The market capitalization of Avalo Therapeutics, Inc. - Common Stock is 1.09B
How many shares of Avalo Therapeutics, Inc. - Common Stock are outstanding?
Avalo Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.